U.S. flag

An official website of the United States government

GRCh38/hg38 1p36.22-36.21(chr1:12264268-13119398)x3 AND See cases

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 27, 2013
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000141874.6

Allele description [Variation Report for GRCh38/hg38 1p36.22-36.21(chr1:12264268-13119398)x3]

GRCh38/hg38 1p36.22-36.21(chr1:12264268-13119398)x3

Genes:
  • LOC129929456:ATAC-STARR-seq lymphoblastoid active region 212 [Gene]
  • LOC129929457:ATAC-STARR-seq lymphoblastoid active region 213 [Gene]
  • LOC126805620:BRD4-independent group 4 enhancer GRCh37_chr1:12763477-12764676 [Gene]
  • LOC126805622:CDK7 strongly-dependent group 2 enhancer GRCh37_chr1:12919058-12920257 [Gene]
  • LOC111591499:NFE2L2 motif-containing MPRA enhancer 265 [Gene]
  • LOC132088624:Neanderthal introgressed variant-containing enhancer experimental_247 [Gene]
  • LOC126805621:P300/CBP strongly-dependent group 1 enhancer GRCh37_chr1:12775588-12776787 [Gene]
  • PRAMEF10:PRAME family member 10 [Gene - HGNC]
  • PRAMEF11:PRAME family member 11 [Gene - HGNC]
  • PRAMEF12:PRAME family member 12 [Gene - HGNC]
  • PRAMEF1:PRAME family member 1 [Gene - HGNC]
  • PRAMEF25:PRAME family member 25 [Gene - HGNC]
  • PRAMEF27:PRAME family member 27 [Gene - HGNC]
  • PRAMEF2:PRAME family member 2 [Gene - HGNC]
  • PRAMEF4:PRAME family member 4 [Gene - HGNC]
  • PRAMEF6:PRAME family member 6 [Gene - HGNC]
  • PRAMEF7:PRAME family member 7 [Gene - HGNC]
  • LOC121967081:Sharpr-MPRA regulatory region 10571 [Gene]
  • LOC120893113:Sharpr-MPRA regulatory region 11784 [Gene]
  • LOC120883623:Sharpr-MPRA regulatory region 1458 [Gene]
  • LOC121967082:Sharpr-MPRA regulatory region 15009 [Gene]
  • LOC112577487:Sharpr-MPRA regulatory region 4366 [Gene]
  • LOC112577488:Sharpr-MPRA regulatory region 5682 [Gene]
  • LOC121967083:Sharpr-MPRA regulatory region 8719 [Gene]
  • AADACL3:arylacetamide deacetylase like 3 [Gene - HGNC]
  • AADACL4:arylacetamide deacetylase like 4 [Gene - HGNC]
  • CFAP107:cilia and flagella associated protein 107 [Gene - HGNC]
  • DHRS3:dehydrogenase/reductase 3 [Gene - OMIM - HGNC]
  • HNRNPCL1:heterogeneous nuclear ribonucleoprotein C like 1 [Gene - HGNC]
  • HNRNPCL2:heterogeneous nuclear ribonucleoprotein C like 2 [Gene - HGNC]
  • HNRNPCL3:heterogeneous nuclear ribonucleoprotein C like 3 [Gene - HGNC]
  • LINC01784:long intergenic non-protein coding RNA 1784 [Gene - HGNC]
  • LINC02766:long intergenic non-protein coding RNA 2766 [Gene - HGNC]
  • MIR6730:microRNA 6730 [Gene - HGNC]
  • SNORA59A:small nucleolar RNA, H/ACA box 59A [Gene - HGNC]
  • VPS13D:vacuolar protein sorting 13 homolog D [Gene - OMIM - HGNC]
Variant type:
copy number gain
Cytogenetic location:
1p36.22-36.21
Genomic location:
Preferred name:
GRCh38/hg38 1p36.22-36.21(chr1:12264268-13119398)x3
HGVS:
  • NC_000001.11:g.(?_12264268)_(13119398_?)dup
  • NC_000001.10:g.(?_12324325)_(13186871_?)dup
Links:
dbVar: nssv3397104; dbVar: nsv995510
Observations:
1

Condition(s)

Name:
See cases [See the Variation display for details]
Identifiers:

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000182933ISCA site 1

See additional submitters

no assertion criteria provided
Uncertain significance
(Sep 27, 2013) 		maternalclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedmaternalyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, et al.

Am J Hum Genet. 2010 May 14;86(5):749-64. doi: 10.1016/j.ajhg.2010.04.006. Review.

PubMed [citation]
PMID:
20466091
PMCID:
PMC2869000

Details of each submission

From ISCA site 1, SCV000182933.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1maternalyesnot providednot providedDiscovery1not providednot providednot provided

Last Updated: May 7, 2024